• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (TSX:SVA)

    0.1300 +0.0025 (+1.96%)
    Streaming Delayed Price Updated: 3:50 PM EST, Dec 19, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about SVA

    < Previous 1 2 3 Next >
    News headline image
    Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines
    Via JCN Newswire
    News headline image
    Indonesia's Bio Farma ready to produce 'IndoVac' Covid-19 vaccines
    Via ACN Newswire
    News headline image
    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
    Via ACN Newswire
    News headline image
    SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
    From Sinovac Biotech Ltd.
    Via Business Wire
    News headline image
    Sinovac Biotech Ltd. (Formerly NASDAQ:SVA) Investor Notice: Lawsuit Alleges Securities Laws Violations by 1Globe Capital LLC ↗
    San Diego, CA -- (SBWIRE) -- 09/02/2022 -- An investor, who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ:SVA), filed a lawsuit over alleged Securities Laws violations by 1Globe Capital... 
    Via SBWire
    News headline image
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers - SVA
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Sinovac Biotech Ltd. (SVA) Investors of Class Action Against 1Globe Capital LLC and to Actively Participate
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    News headline image
    SINOVAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sinovac Biotech Ltd. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    News headline image
    EQUITY ALERT: Rosen Law Firm Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    News headline image
    SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
    From Sinovac Biotech Ltd.
    Via Business Wire
    News headline image
    SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
    From Sinovac Biotech Ltd.
    Via Business Wire
    News headline image
    SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
    From Sinovac Biotech Ltd.
    Via Business Wire
    News headline image
    Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out ↗
     
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022 ↗
    Upgrades 
    Via Benzinga
    News headline image
    SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
    From Sinovac Biotech Ltd.
    Via Business Wire
    News headline image
    SINOVAC Polio Vaccine Prequalified by WHO
    From SINOVAC Biotech Ltd.
    Via Business Wire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.